美股异动 | 次新股Turn Therapeutics(TTRX.US)涨超144% 致力于开发下一代皮肤病、伤口和抗感染疗法

Core Viewpoint - Turn Therapeutics (TTRX.US) stock price surged over 144%, reaching $16.95, indicating strong market interest and potential investor confidence in the company's innovative therapies [1] Company Overview - Turn Therapeutics focuses on developing next-generation therapies for skin diseases, wounds, and infections [1] - The company utilizes a proprietary delivery platform technology called "PermaFusion®" [1] Technology and Innovation - The "PermaFusion®" technology allows water-soluble active ingredients to penetrate the skin, nails, or mucous membranes using an oil-based carrier without the need for emulsifiers [1] - This technology aims to enhance the availability of active ingredients while reducing irritation [1]